Saturday


0700 - 0730

Registration Desk Opens / Continental Breakfast

0730 - 0745

Welcome – Dr. Jagdish Butany, University Health Network, Toronto, ON

0745 - 0830

“Diagnostic Immunohistochemistry”
Dr. Kelly Dakin-Hache, QEII Health Sciences Centre Halifax, NS
(35 minute presentation, 10-minute Q&A)
At the end of this session, participants will be able to:

  • Explain the importance of the pre-analytic phase in quality and validity of immunohistochemistry stains
  • Describe the technical components of an immunohistochemistry test and list the types of controls which should be used
  • List the important components of new test validation for both class I and class II immunostains

0835 - 0935

 

Quality Assurance in Hematological Pathology
Dr. Ruth Frances Padmore, University of Ottawa, Ottawa, ON
 (45-minute presentation, 15 minutes Q&A)

At the end of this session, participants will be able to:

  • Describe quality in the hematology laboratory
  • List critical results – how are they handled
  • Recognize safety in the Laboratory
  • List laboratory errors (pre analytic, analytic and post analytic)
  • Describe instrument selection and validation

0935 - 1100

A Case Based Approach In Blood Transfusion
Dr. Irene Sadek , Dalhousie University, Halifax, NS
(70-minute presentation, 20 minutes Q&A)

At the end of this session, participants will be able to:

  • Describe complex cases in transfusion medicine
  • Identify clinical problems in replacement therapy
  • Describe technical aspects of blood banking
  • List issues in laboratory utilization in transfusion medicine

1035 - 1050

Refreshment Break

1100 - 1130

“Quality Assurance In Transfusion Medicine’’
Dr.  Irene Sadek, Dalhousie University, Halifax, NS
(20-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Explain the purpose and basic principles of a quality assurance program in transfusion medicine
  • List at least six (6) basis components of a transfusion medicie QA program
  • Describe at least three (3) strategies through which error identification can lead to quality improvement as part of a quality assurance program in transfusion medicine

1130 - 1245

Luncheon Seminar
Dr. Brian Cummings, Grand River Hospital, Kitchener-Waterloo, ON


1245 - 1345

“An Approach to Hemoglobinopathy Investigations”
Dr. Elaine Leung, University of Ottawa, Ottawa, ON
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Describe a practical approach to the investigation of the hemoglobinopathies
  • List the implications of the common haemoglobinopthies encountered in a clinical setting and how to advise clinicians regarding testing results
  • Demonstrate when to refer samples to a reference lab for further investigations
  • Describe the interpretation of hemoglobinopathy investigations throughout infancy and early childhood

1345 - 1445

“Coagulation and Thrombosis Selected Topics In Lab Hematology”
Dr. Artur Szkotak, Alberta Health Services, Edmonton, AB
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • List the key pre-analytic issues unique to coagulation testing
  • Describe how to validate the INR for PT reporting
  • Restate how to validate the Heparin Therapeutic Range for PTT reporting

1445 - 1500

Refreshment Break

1500 - 1600

Approach to Pediatric Hematopathology Pathology
Chantale Pambrun IWK  Dalhousie University, Halifax, NS
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Describe bone marrow failure syndrome
  • Describe coagulation problems inpediatrics
  • recognize acute leukemia in Childhood

1600 - 1700

“The Molecular Genetics of Myeloid Malignancies”
Dr Aly Karsan, BC Cancer Agency and University of British Columbia Vancouver, BC
(50-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • List the key pre-analytic, analytic and post-analytic steps of next-generation sequencing
  • Describe principal genes or gene families that are mutated in acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
  • Apply knowledge of the genetic alterations in myeloid malignancies to hematopathology practice

Sunday

0700 - 0730

Continental Breakfast - Early start!

0800 - 0830

"Approach to the Hematological Pathology Fellowship Examination"
Dr. Clinton Campbell, University of Ottawa, Ottawa, ON
(10-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Describe the overall format of the RCPSC exam in Hematological Pathology
  • Report on their additional knowledge of the evaluation processes that guide the HP examination
  • List techniques to maximize success in all components of the exam

0830 - 0930

“The Standardized Bone Marrow Examination: Pearls For Senior Residents In Transition To Practice’’
 Dr. Clinton Campbell, Dalhousie University, Halifax, NS
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Review of standardized (ICSH, CAP, WHO) guidelines for bone marrow examination
  • Review of process and ICSH standardized guidelines for bone marrow IHC
  • Discuss key topics important for the RCPSC exam preparation and transition to practice
  • Brief overview of QC/QA pertaining to bone marrow

0930 - 1000

Molecular diagnostics as applies to the current practice of Hematopathology and transition from residency
Dr. Philip Berardi, The Ottawa Hospital, Ottawa, ON
(20-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Review the principles of molecular diagnostic testing as applied to complex malignant hematology
  • Examine the difference between an approved commercially available test and a validated laboratory developed test
  • Elaborate on clinically actionable mutations and predictive markers
  • Critically appraise how monitoring by molecular methods in some hematolymphoid neoplasms can help predict long term survival
  • Develop an approach to laboratory management and quality assurance as it pertains to molecular diagnostics

1000 - 1015

Refreshment Break

1015 - 1130

“Application of Molecular Pathology in Solid and Liquid Tumours”
Dr. Christopher Howlett, University of Western Ontario, London, ON
(60-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • List molecular tests relevant to practice in Pathology
  • Explain the rationale for performing common molecular tests to improve accuracy of diagnosis in solid and liquid tumours
  • Discuss the role of particular molecular tests in predicting tumour response to therapy

1130 - 1230

Lunch

1230 - 1330

“Approach to Work-up and Diagnosis of Hematological Disorders”
Dr. Monalisa Sur, McMaster University, Hamilton, ON
(45-minute presentation, 15-minute Q&A)

At the end of this session, participants will be able to:

  • Handle various specimens in the lab with a clinical diagnosis of a lymphoproliferative disorder
  • Work up common reactive lymphadenopathies
  • Use a pattern based approach to create a differential diagnosis and distinguish various indolent and aggressive lymphomas
  • Describe the role (in diagnosis and prognosis) and judicious use of various ancillary tests such as immunohistochemistry, flow cytometry and molecular tests

1330 - 1430

“Bone Marrow evaluation and Flow Cytometry”
Dr. Graham Quest, 
(45-minute presentation, 15-minute Q&A)
At the end of this session, participants will be able to:

  • Follow the principles of integrated bone marrow diagnostics
  • Compare normal vs. abnormal patterns of the main antigen combinations used in the flow cytometric diagnosis of bone marrow
  • Summarize principles of flow cytometry diagnostics of hematological malignancies

1430 - 1515

“Practical Approach to Hematological Evaluation of Peripheral Blood”
Dr. Allam Shawwa, Queen Elizabeth II Health Science Centre, Halifax, NS
(35-minute presentation, 10-minute Q&A)

At the end of this session, participants will be able to:

  • Describe a practical approach to diagnosis of anemia
  • Describe an approach to diagnosis of acute leukemia, myeloproliferative and myelodysplastic disorders 
  • Describe a practical approach to lymphocytosis with update on small lymphocyte disorders

1515 - 1545  

Closing Remarks 

 


- last updated December 2017 -